Glaukos (GKOS) Total Non-Current Liabilities (2014 - 2026)
Glaukos (GKOS) posted quarterly Total Non-Current Liabilities of $205.6 million for Q2 2026, up 7.61% year-over-year from $191.1 million in Q2 2025, and up 6.58% quarter-over-quarter from $192.9 million in Q1 2026.
Glaukos (GKOS) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Total Non-Current Liabilities for 13 consecutive years, with $205.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Non-Current Liabilities rose 7.61% year-over-year to $205.6 million; the TTM figure through Jun 2026 stood at $205.6 million (up 7.61% YoY), while the FY2025 annual figure was $205.6 million, up 10.86% from the prior year.
- Total Non-Current Liabilities advanced to $205.6 million in Q2 2026 per GKOS's latest filing, from $192.9 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $482.6 million in Q1 2024 and bottomed at $180.9 million in Q1 2025.
- Historically, Total Non-Current Liabilities has averaged $331.2 million across 5 years, with a median of $340.6 million in 2022.
- On a YoY basis, Total Non-Current Liabilities climbed as much as 10.86% in 2025 and fell as far as 62.51% in 2025.
- Glaukos' Total Non-Current Liabilities stood at $462.1 million in 2022, then advanced by 0.61% to $464.9 million in 2023, then plunged by 60.11% to $185.5 million in 2024, then climbed by 10.86% to $205.6 million in 2025, then climbed by 0.01% to $205.6 million in 2026.
- Business Quant data shows GKOS's Total Non-Current Liabilities at $205.6 million in Q2 2026, $192.9 million in Q1 2026, and $205.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Glaukos | 11.08 Bn | 10.96 Bn | 151.59 Mn | 205.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 205.61 Mn |
| Mar 31, 2026 | 192.91 Mn |
| Dec 31, 2025 | 205.59 Mn |
| Sep 30, 2025 | 198.75 Mn |
| Jun 30, 2025 | 191.07 Mn |
| Mar 31, 2025 | 180.93 Mn |
| Dec 31, 2024 | 185.45 Mn |
| Sep 30, 2024 | 235.95 Mn |
| Jun 30, 2024 | 233.84 Mn |
| Mar 31, 2024 | 482.61 Mn |
| Dec 31, 2023 | 464.90 Mn |
| Sep 30, 2023 | 458.18 Mn |
| Jun 30, 2023 | 455.02 Mn |
| Mar 31, 2023 | 452.89 Mn |
| Dec 31, 2022 | 462.10 Mn |
| Sep 30, 2022 | 450.42 Mn |
| Jun 30, 2022 | 459.35 Mn |
| Mar 31, 2022 | 445.18 Mn |
| Dec 31, 2021 | 453.05 Mn |
| Sep 30, 2021 | 454.10 Mn |